Cover Image
市場調查報告書

分子診斷的全球市場 (各技術 (PCR/即時PCR、混合化、微陣列、轉錄擴增、次世代定序):產業分析),市場規模、佔有率、成長率、趨勢、未來預測

Molecular Diagnostics Market (Technology - PCR and Real-Time PCR, Hybridization, Microarray, Transcription-mediated Amplification, and Next-Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

出版商 Transparency Market Research 商品編碼 294642
出版日期 內容資訊 英文 164 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
分子診斷的全球市場 (各技術 (PCR/即時PCR、混合化、微陣列、轉錄擴增、次世代定序):產業分析),市場規模、佔有率、成長率、趨勢、未來預測 Molecular Diagnostics Market (Technology - PCR and Real-Time PCR, Hybridization, Microarray, Transcription-mediated Amplification, and Next-Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
出版日期: 2017年01月25日 內容資訊: 英文 164 Pages
簡介

全球各地慢性感染疾病 (結核,HIV/AIDS,肺炎等)的發病數量上升,及老年人口的增加,生物科技企業的增加等,使分子診斷市場成長率上升。

本報告提供全球分子診斷的市場相關分析,市場基本結構和特徵,主要的推動及阻礙市場要素,整體市場規模趨勢預測 (以金額為準),各技術、各用途、各終端用戶產業、各地區的詳細趨勢,企業間競爭現況,主要企業簡介等的相關調查。

第1章 序論

第2章 前提條件、分析方法

第3章 摘要整理:全球分子診斷市場

第4章 市場概要

  • 簡介
    • 產品定義
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 市場機會

第5章 全球分子診斷市場分析與預測 (今後9年份)

  • 市場收益額的預測
  • 波特的五力分析
  • 市場未來展望

第6章 全球分子診斷市場分析與預測:各技術

  • 簡介、定義
  • 分析的要點
  • 主要趨勢
  • 市場規模的預測:各技術 (以金額為準)
    • PCR (聚合酵素鏈鎖反應) 及即時PCR
    • 混合化
    • 微陣列
    • 轉錄擴增 (TMA)
    • 次世代定序
    • 其他 (質譜分析等)
  • 市場向心力:各技術

第7章 全球分子診斷市場分析與預測:各用途

  • 簡介、定義
  • 分析的要點
  • 主要趨勢
  • 市場規模的預測:各用途 (以金額為準)
    • 感染疾病 (病毒檢驗、細菌檢驗)
    • 腫瘤
    • 微生物
    • 遺傳基因檢驗
    • 婦產科疾病
  • 市場向心力:各用途

第8章 全球分子診斷市場分析與預測:各終端用戶

  • 分析的要點
  • 政策、規定
  • 市場規模的預測:各終端用戶 (以金額為準)
    • 醫院
    • 診斷測試所
    • 血庫
    • 教育、研究機關
    • 其他
  • 市場向心力:各終端用戶

第9章 全球分子診斷市場分析與預測:各地區

  • 分析的要點
  • 政策、規定
  • 市場規模的預測:各地區 (以金額為準)
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 市場向心力:各地區

第10章 北美的分子診斷市場分析與預測

  • 簡介、定義
  • 分析的要點
  • 主要趨勢
  • 市場規模的預測:各技術
  • 市場規模的預測:各用途
  • 市場規模的預測:各終端用戶
  • 市場規模的預測:各國 (美國,加拿大)
  • 市場向心力分析:各技術,各用途,各終端用戶,各國

第11章 北美的分子診斷市場分析與預測

  • 簡介、定義
  • 分析的要點
  • 主要趨勢
  • 市場規模的預測:各技術
  • 市場規模的預測:各用途
  • 市場規模的預測:各終端用戶
  • 市場規模的預測:各國 (德國,法國,英國,義大利,西班牙等)
  • 市場向心力分析:各技術,各用途,各終端用戶,各國

第12章 亞太地區的分子診斷市場分析與預測

  • 簡介、定義
  • 分析的要點
  • 主要趨勢
  • 市場規模的預測:各技術
  • 市場規模的預測:各用途
  • 市場規模的預測:各終端用戶
  • 市場規模的預測:各國 (中國,日本,澳洲,印度等)
  • 市場向心力分析:各技術,各用途,各終端用戶,各國

第13章 南美的分子診斷市場分析與預測

  • 簡介、定義
  • 分析的要點
  • 主要趨勢
  • 市場規模的預測:各技術
  • 市場規模的預測:各用途
  • 市場規模的預測:各終端用戶
  • 市場規模的預測:各國 (巴西,墨西哥等)
  • 市場向心力分析:各技術,各用途,各終端用戶,各國

第14章 中東、非洲 (MEA)的分子診斷市場分析與預測

  • 簡介、定義
  • 分析的要點
  • 主要趨勢
  • 市場規模的預測:各技術
  • 市場規模的預測:各用途
  • 市場規模的預測:各終端用戶
  • 市場規模的預測:各國 (沙烏地阿拉伯,南非等)
  • 市場向心力分析:各技術,各用途,各終端用戶,各國

第15章 競爭環境

  • 主要企業的競爭力矩陣 (比較表):企業規模、排行榜
  • 市場佔有率分析:各企業
  • 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Title: Molecular Diagnostics Market (Technology - PCR and Real-Time PCR, Hybridization, Microarray, Transcription-mediated Amplification, and Next-Generation Sequencing; Application - Infectious Diseases, Oncology, Blood Screening, Microbiology, Genetic Testing, and Women's Health; End User: Hospitals, Diagnostic Laboratories, Blood Banks, Academics, and Research) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025.

Global Molecular Diagnostics Market: Overview

This report on the molecular diagnostics market studies the current and future prospects of the market globally. Growing incidences of chronic infectious diseases such as tuberculosis, HIV/AIDS, diarrhea, pneumonia hepatitis, in addition to increasing geriatric population, and rising number of biotechnology companies is expected to accentuate the growth of global molecular diagnostics market. The global molecular diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global molecular diagnostics market with respect to market segments based on technology, application, end user and their geographic analysis.

Global Molecular Diagnostics Market: Segmentation

Based on technology, the molecular diagnostics market has been segmented into six major categories: PCR and real-time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing and others which includes mass spectrometry etc. These are the major techniques which are used in molecular diagnostics for diagnosis of disease. Likewise, on the basis of application, the global molecular diagnostics market has been segmented into infectious diseases, oncology, blood screening, microbiology, genetic testing and women's health. Infectious disease testing has been segmented into two major categories, namely, virology and bacteriology. The market segments have been extensively analyzed based on usefulness, adoption, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2015 to 2025. The molecular diagnostics market report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2015 as the base year. A brief patient pool analysis by infectious disease, cancer and cardiovascular disease have also been discussed in the global molecular diagnostics report.

Based on End User the global molecular diagnostics market is segmented as hospitals, diagnostic laboratories, blood banks, academics & research and others. The market size and forecast for each of these end user has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year.

Global Molecular Diagnostics Market: Regional Outlook

Geographically, the molecular diagnostics market in Europe has been categorized into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving that is supply side driver, demand side driver and economic driver, restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter's Five Forces analysis, and market share analysis by key players, competitive matrix thus presenting a thorough analysis of the overall competitive scenario in the global molecular diagnostics market.

Key Players Mentioned in this Report are:

Current and future trends has also been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the global molecular diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments, SWOT analysis. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN N.V. ,bioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG and Thermo Fisher Scientific Inc., and others.

The global molecular diagnostics market is segmented as given below:

Global Molecular Diagnostics Market, by Technology

  • PCR and Real-Time PCR
  • Hybridization
  • Microarray
  • Transcription-Mediated Amplification
  • Next-Generation Sequencing
  • Others (Mass Spectrometry, etc.)

Global Molecular Diagnostics Market, by Application

  • Infectious Diseases
  • Oncology
  • Blood Screening
  • Microbiology
  • Genetic Testing
  • Women's Health

Global Molecular Diagnostics Market, by End Use

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Academics
  • Research

Global Molecular Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market definition and scope
  • 1.2. Market segmentation
  • 1.3. Key research objectives
  • 1.4. Research highlights

2. Assumptions and research methodology

3. Executive summary: global molecular diagnostics market

4. Market overview

  • 4.1. Introduction
    • 4.1.1. Product definition
  • 4.2. Market dynamics
    • 4.2.1. Drivers
      • 4.2.1.1. Economic drivers
      • 4.2.1.2. Supply side drivers
      • 4.2.1.3. Demand side drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities

5. Global Molecular Diagnostics Market Analysis and Forecast, 2017-2025

  • 5.1. Market Revenue Projections (US$ Mn)
  • 5.2. Porter's Five forces Analysis: Global Molecular Diagnostics Market
  • 5.3. Future Market Outlook

6. Global Molecular Diagnostics Market Analysis and Forecast, By Technology

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Key Trends
  • 6.4. Market Value (US$ Mn) Forecast By Technology
    • 6.4.1. PCR and Real-Time PCR
    • 6.4.2. Hybridization
    • 6.4.3. Microarray
    • 6.4.4. Transcription-Mediated Amplification
    • 6.4.5. Next-Generation Sequencing
    • 6.4.6. Others (Mass Spectrometry etc.)
  • 6.5. Market Attractiveness By Technology

7. Global Molecular Diagnostics Market Analysis and Forecast, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Key Trends
  • 7.4. Market Value (US$ Mn) Forecast By Application
    • 7.4.1. Infectious Diseases
      • 7.4.1.1. Virology
      • 7.4.1.2. Bacteriology
    • 7.4.2. Oncology
    • 7.4.3. Blood Screening
    • 7.4.4. Microbiology
    • 7.4.5. Genetic Testing
    • 7.4.6. Women's Health
  • 7.5. Market Attractiveness By Application

8. Global Molecular Diagnostics Market Analysis and Forecasts, By End User

  • 8.1. Key Findings
  • 8.2. Policies and Regulations
  • 8.3. Market Value (US$ Mn) Forecast By End User
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostics Laboratories
    • 8.3.3. Blood Banks
    • 8.3.4. Academics & Research
    • 8.3.5. Others
  • 8.4. Market Attractiveness By End User

9. Global Molecular Diagnostics Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Policies and Regulations
  • 9.3. Market Value (US$ Mn) Forecast By Region
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East and Africa
  • 9.4. Market Attractiveness By Region

10. North America Molecular Diagnostics Market Analysis and Forecast

  • 10.1. Key Findings
  • 10.2. Policies and Regulations
  • 10.3. Key Trends
  • 10.4. Market Value (US$ Mn) Forecast By Technology
    • 10.4.1. PCR and Real-Time PCR
    • 10.4.2. Hybridization
    • 10.4.3. Microarray
    • 10.4.4. Transcription-Mediated Amplification
    • 10.4.5. Next-Generation Sequencing
    • 10.4.6. Others (Mass Spectrometry etc.)
  • 10.5. Market Value (US$ Mn) and Forecast By Application
    • 10.5.1. Infectious Diseases
      • 10.5.1.1. Virology
      • 10.5.1.2. Bacteriology
    • 10.5.2. Oncology
    • 10.5.3. Blood Screening
    • 10.5.4. Microbiology
    • 10.5.5. Genetic Testing
    • 10.5.6. Women's Health
  • 10.6. Market Value (US$ Mn) Forecast By End User
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostics Laboratories
    • 10.6.3. Blood Banks
    • 10.6.4. Academics & Research
    • 10.6.5. Others
  • 10.7. Market Value (US$ Mn) Forecast By Country
    • 10.7.1. U.S.
    • 10.7.2. Canada
  • 10.8. Market Attractiveness Analysis
    • 10.8.1. By Technology
    • 10.8.2. By Application
    • 10.8.3. By End User
    • 10.8.4. By Country

11. Europe Molecular Diagnostics Market Analysis and Forecast

  • 11.1. Key Findings
  • 11.2. Policies and Regulations
  • 11.3. Key Trends
  • 11.4. Market Value (US$ Mn) Forecast By Technology
    • 11.4.1. PCR and Real-Time PCR
    • 11.4.2. Hybridization
    • 11.4.3. Microarray
    • 11.4.4. Transcription-Mediated Amplification
    • 11.4.5. Next-Generation Sequencing
    • 11.4.6. Others (Mass Spectrometry etc.)
  • 11.5. Market Value (US$ Mn) Forecast By Application
    • 11.5.1. Infectious Diseases
      • 11.5.1.1. Virology
      • 11.5.1.2. Bacteriology
    • 11.5.2. Oncology
    • 11.5.3. Blood Screening
    • 11.5.4. Microbiology
    • 11.5.5. Genetic Testing
    • 11.5.6. Women's Health
  • 11.6. Market Value (US$ Mn) Forecast By End User
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostics Laboratories
    • 11.6.3. Blood Banks
    • 11.6.4. Academics & Research
    • 11.6.5. Others
  • 11.7. Market Value (US$ Mn) Forecast By Country
    • 11.7.1. Germany
    • 11.7.2. France
    • 11.7.3. U.K.
    • 11.7.4. Italy
    • 11.7.5. Spain
    • 11.7.6. Rest of Europe
  • 11.8. Market Attractiveness Analysis
    • 11.8.1. By Technology
    • 11.8.2. By Application
    • 11.8.3. By End User
    • 11.8.4. By Country

12. Asia Pacific Molecular Diagnostics Market Analysis and Forecast

  • 12.1. Key Findings
  • 12.2. Policies and Regulations
  • 12.3. Key Trends
  • 12.4. Market Value (US$ Mn) Forecast By Technology
    • 12.4.1. PCR and Real-Time PCR
    • 12.4.2. Hybridization
    • 12.4.3. Microarray
    • 12.4.4. Transcription-Mediated Amplification
    • 12.4.5. Next-Generation Sequencing
    • 12.4.6. Others (Mass Spectrometry etc.)
  • 12.5. Market Value (US$ Mn) Forecast By Application
    • 12.5.1. Infectious Diseases
      • 12.5.1.1. Virology
      • 12.5.1.2. Bacteriology
    • 12.5.2. Oncology
    • 12.5.3. Blood Screening
    • 12.5.4. Microbiology
    • 12.5.5. Genetic Testing
    • 12.5.6. Women's Health
  • 12.6. Market Value (US$ Mn) Forecast By End User
    • 12.6.1. Hospitals
    • 12.6.2. Diagnostics Laboratories
    • 12.6.3. Blood Banks
    • 12.6.4. Academics & Research
    • 12.6.5. Others
  • 12.7. Market Value (US$ Mn) Forecast By Country
    • 12.7.1. China
    • 12.7.2. Japan
    • 12.7.3. Australia
    • 12.7.4. India
    • 12.7.5. Rest of Asia Pacific
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Technology
    • 12.8.2. By Application
    • 12.8.3. By End User
    • 12.8.4. By Country

13. Latin America Molecular Diagnostics Market Analysis and Forecast

  • 13.1. Key Findings
  • 13.2. Policies and Regulations
  • 13.3. Key Trends
  • 13.4. Market Value (US$ Mn) Forecast By Technology
    • 13.4.1. PCR and Real-Time PCR
    • 13.4.2. Hybridization
    • 13.4.3. Microarray
    • 13.4.4. Transcription-Mediated Amplification
    • 13.4.5. Next-Generation Sequencing
    • 13.4.6. Others (Mass Spectrometry etc.)
  • 13.5. Market Value (US$ Mn) Forecast By Application
    • 13.5.1. Infectious Diseases
      • 13.5.1.1. Virology
      • 13.5.1.2. Bacteriology
    • 13.5.2. Oncology
    • 13.5.3. Blood Screening
    • 13.5.4. Microbiology
    • 13.5.5. Genetic Testing
    • 13.5.6. Women's Health
  • 13.6. Market Value (US$ Mn) Forecast By End User
    • 13.6.1. Hospitals
    • 13.6.2. Diagnostics Laboratories
    • 13.6.3. Blood Banks
    • 13.6.4. Academics & Research
    • 13.6.5. Others
  • 13.7. Market Value (US$ Mn) Forecast By Country
    • 13.7.1. Brazil
    • 13.7.2. Mexico
    • 13.7.3. Rest of Latin America
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Technology
    • 13.8.2. By Application
    • 13.8.3. By End User
    • 13.8.4. By Country

14. Middle East and Africa Molecular Diagnostics Market Analysis and Forecast

  • 14.1. Key Findings
  • 14.2. Policies and Regulations
  • 14.3. Key Trends
  • 14.4. Market Value (US$ Mn) Forecast By Technology
    • 14.4.1. PCR and Real-Time PCR
    • 14.4.2. Hybridization
    • 14.4.3. Microarray
    • 14.4.4. Transcription-Mediated Amplification
    • 14.4.5. Next-Generation Sequencing
    • 14.4.6. Others (Mass Spectrometry etc.)
  • 14.5. Market Value (US$ Mn) Forecast By Application
    • 14.5.1. Infectious Diseases
      • 14.5.1.1. Virology
      • 14.5.1.2. Bacteriology
    • 14.5.2. Oncology
    • 14.5.3. Blood Screening
    • 14.5.4. Microbiology
    • 14.5.5. Genetic Testing
    • 14.5.6. Women's Health
  • 14.6. Market Value (US$ Mn) Forecast By End User
    • 14.6.1. Hospitals
    • 14.6.2. Diagnostics Laboratories
    • 14.6.3. Blood Banks
    • 14.6.4. Academics & Research
    • 14.6.5. Others
  • 14.7. Market Value (US$ Mn) Forecast By Country
    • 14.7.1. Saudi Arabia
    • 14.7.2. South Africa
    • 14.7.3. Rest of MEA
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Technology
    • 14.8.2. By Application
    • 14.8.3. By End User
    • 14.8.4. By Country

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2015)
  • 15.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 15.3.1. Abbott Laboratories
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Business Overview
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Becton, Dickinson and Company
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Business Overview
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Bio-Rad Laboratories, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Business Overview
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. BioMérieux SA
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Business Overview
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Danaher Corporation
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Business Overview
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. F. Hoffmann-La Roche Ltd.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Business Overview
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. QIAGEN N.V.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Business Overview
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Siemens AG
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Business Overview
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Thermo Fisher Scientific Inc.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Business Overview
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview

List of Figures

  • Figure 1: Global Molecular Diagnostic Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 2: Global Molecular Diagnostics Market Value Share, by Technology (2017)
  • Figure 3: Global Molecular Diagnostics Market Value Share, by Application (2017)
  • Figure 4: Global Molecular Diagnostics Market Value Share, by Region (2017)
  • Figure 5: Global Molecular Diagnostics Market Value Share, by End-user (2017)
  • Figure 6: Global Molecular Diagnostic Market Value Share Analysis, by Technology, 2017 and 2025
  • Figure 7: Global Molecular Diagnostic Market Attractiveness Analysis, by Technology, 2016
  • Figure 8: Global PCR and Real-Time PCR Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 9: Global Hybridization Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 10: Global Microarray Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 11: Global Transcription-Mediated Amplification Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 12: Global Next-Generation Sequencing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 13: Global Others (Mass Spectrometry etc.) Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 14: Global Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2025
  • Figure 15: Global Molecular Diagnostics Market Attractiveness Analysis, by Application, 2016
  • Figure 16: Global Infectious Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 17: Global Oncology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 18: Global Blood Screening Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 19: Global Microbiology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 20: Global Genetic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 21: Global Women's Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 22: Global Molecular Diagnostic Market Value Share Analysis, by End-user, 2017 and 2025
  • Figure 23: Global Molecular Diagnostic Market Attractiveness Analysis, by End-user, 2016
  • Figure 24: Global Hospital Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 25: Global Diagnostic Laboratories Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 26: Global Blood Banks Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 27: Global Academics & Research Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 28: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 29: Global Molecular Diagnostics Market Value Share Analysis, by Region, 2017 and 2025
  • Figure 30: Global Molecular Diagnostics Market Attractiveness Analysis, by Region, 2016
  • Figure 31: North America Molecular Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 32: North America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
  • Figure 33: North America Market Value Share Analysis, by Technology Type, 2017 and 2025
  • Figure 34: North America Market Value Share Analysis, by Application, 2017 and 2025
  • Figure 35: North America Market Value Share Analysis, by End-user, 2017 and 2025
  • Figure 36: North America Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 37: North America Market Attractiveness Analysis, by Technology
  • Figure 38: North America Market Attractiveness Analysis, by Application
  • Figure 39: North America Market Attractiveness Analysis, by End-user
  • Figure 40: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 41: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
  • Figure 42: Europe Molecular Diagnostics Market Value Share Analysis, by Technology, 2017 and 2025
  • Figure 43: Europe Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2025
  • Figure 44: Europe Molecular Diagnostics Market Value Share Analysis, by End-user, 2017 and 2025
  • Figure 45: Europe Molecular Diagnostics Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 46: Europe Molecular Diagnostics Market Attractiveness Analysis, by Technology
  • Figure 47: Europe Molecular Diagnostics Market Attractiveness Analysis, by Application
  • Figure 48: Europe Molecular Diagnostics Market Attractiveness Analysis, by End-user
  • Figure 49: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 50: Asia Pacific Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
  • Figure 51: Asia Pacific Market Value Share Analysis, by Technology Type, 2017 and 2025
  • Figure 52: Asia Pacific Market Value Share Analysis, by Application, 2017 and 2025
  • Figure 53: Asia Pacific Market Value Share Analysis, by End-user, 2017 and 2025
  • Figure 54: Asia Pacific Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 55: Asia Pacific Market Attractiveness Analysis, by Technology
  • Figure 56: Asia Pacific Market Attractiveness Analysis, by Application
  • Figure 57: Asia Pacific Market Attractiveness Analysis, by End-user
  • Figure 58: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 59: Latin America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
  • Figure 60: Latin America Market Value Share Analysis, by Technology Type, 2017 and 2025
  • Figure 61: Latin America Market Value Share Analysis, by Application, 2017 and 2025
  • Figure 62: Latin America Market Value Share Analysis, by End-user, 2017 and 2025
  • Figure 63: Latin America Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 64: Latin America Market Attractiveness Analysis, by Technology
  • Figure 65: Latin America Market Attractiveness Analysis, by Application
  • Figure 66: Latin America Market Attractiveness Analysis, by End-user
  • Figure 67: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 68: Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis By Country, 2016
  • Figure 69: Middle East & Africa Market Value Share Analysis, by Technology Type, 2017 and 2025
  • Figure 70: Middle East & Africa Market Value Share Analysis, by Application, 2017 and 2025
  • Figure 71: Middle East & Africa Market Value Share Analysis, by End User, 2017 and 2025
  • Figure 72: Middle East & Africa Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 73: Middle East & Africa Market Attractiveness Analysis, by Technology
  • Figure 74: Middle East & Africa Market Attractiveness Analysis, by Application
  • Figure 75: Middle East & Africa Market Attractiveness Analysis, by End User
  • Figure 76: Global Molecular Diagnostics Market Share Analysis, by Company

List of Tables

  • Table 1: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015-2025
  • Table 2: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 3: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015-2025
  • Table 4: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 5: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 06: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015-2025
  • Table 07: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 08: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015-2025
  • Table 09: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 10: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 11: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015-2025
  • Table 12: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 13: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015-2025
  • Table 14: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 15: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 16: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015-2025
  • Table 17: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 18: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015-2025
  • Table 19: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 20: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 21: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015-2025
  • Table 22: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 23: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015-2025
  • Table 24: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 25: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 26: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015-2025
  • Table 27: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, By Application, 2015-2025
  • Table 28: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, By Infectious Diseases, 2015-2025
  • Table 29: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015-2025
  • Table 30: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015-2025
Back to Top